Basit öğe kaydını göster

dc.contributor.authorYakaryilmaz, Fahri
dc.contributor.authorGurbuz, Oguz Alp
dc.contributor.authorGuliter, Sefa
dc.contributor.authorMert, Ali
dc.contributor.authorSongur, Yildiran
dc.contributor.authorKarakan, Tarkan
dc.contributor.authorKeles, Hatice
dc.date.accessioned2020-06-25T17:41:16Z
dc.date.available2020-06-25T17:41:16Z
dc.date.issued2006
dc.identifier.issn0886-022X
dc.identifier.urihttps://doi.org/10.1080/08860220600925602
dc.identifier.urihttps://hdl.handle.net/20.500.12587/3671
dc.description1st John H Dirks Chronic Renal Disease Prevention on Prevention Strategies for Chronic Kidney Disease in Latin America -- NOV 21-23, 2005 -- Vallarica, CHILEen_US
dc.descriptionkarakan, tarkan/0000-0003-1561-8789; Mert, Ali/0000-0001-8945-2385en_US
dc.descriptionWOS: 000242523200018en_US
dc.descriptionPubMed: 17162434en_US
dc.description.abstractBackground and Objective. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are important causes of morbidity and mortality in maintenance hemodialysis patients. Although their exact prevalence is not known, HBV and HCV viral infections and occult viral hepatitis are frequent in these patients. This study aimed to determine the prevalence of occult HBV and HCV infections in maintenance hemodialysis patients. Materials and Methods. One hundred and eighty-eight end-stage renal disease patients on maintenance hemodialysis (100 male, mean age 49 29 [16-80] years, and mean duration of hemodialysis 98 66 [12-228] months) were enrolled in this study. Scrological markers for HBV and HCV were determined with immunoenzymatic assay (ELISA) by using commercial diagnostic kits (Access and BioRad, Beckman-Coulter). HCV-RNA (Cobas Amplicor HCV kit) and HBV-DNA (Artus GmbH HBV kit) were determined quantitatively by polymerase chain reaction. Results. Among the patients screened, 25 (13.3%) had HBV infection alone and 38 (20.2%) had HCV infection alone, while seven (3.7%) had dual infection of both viruses. Serological markers for occult hepatitis B and occult hepatitis C were positive in five (2.7%) and nine (4.8%) of the patients, respectively. Isolated anti-HBc was positive in 12 (6.4%) of all patients, three (7.9%) of the patients with anti-HCV and two (40%) of the patients with occult hepatitis B. Isolated anti-HBc positivity was more frequent in patients with occult hepatitis B than in those without (40% [2/5] vs. 5.5% [10/183], p=0.002). None of the patients with HCV had occult hepatitis B. Conclusions. Both occult and non-occult forms of HCV infection are more prevalent than HBV infection in hemodialysis patients. Especially the patients with isolated anti-HBc positivity should be tested for probable occult hepatitis B infection.en_US
dc.language.isoengen_US
dc.publisherTaylor & Francis Incen_US
dc.relation.isversionof10.1080/08860220600925602en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjecthemodialysisen_US
dc.subjectoccult hepatitisen_US
dc.subjectchronic renal failureen_US
dc.titlePrevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patientsen_US
dc.typearticleen_US
dc.contributor.departmentKırıkkale Üniversitesien_US
dc.identifier.volume28en_US
dc.identifier.issue8en_US
dc.identifier.startpage729en_US
dc.identifier.endpage735en_US
dc.relation.journalRenal Failureen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster